NS3型
变构调节
黄病毒
蛋白酶
病毒学
登革热病毒
化学
寨卡病毒
药物发现
生物
酶
登革热
病毒
生物化学
作者
Jacqueto Zephyr,Desaboini Nageswara Rao,Colby Johnson,Ala M. Shaqra,Ellen A. Nalivaika,Aria Jordan,Nese Kurt Yilmaz,Akbar Ali,Celia A. Schiffer
标识
DOI:10.1016/j.bioorg.2022.106269
摘要
Viruses from the Flavivirus genus infect millions of people worldwide and cause severe diseases, including recent epidemics of dengue virus (DENV), and Zika virus (ZIKV). There is currently no antiviral treatment against flavivirus infections, despite considerable efforts to develop inhibitors against essential viral enzymes including NS2B/NS3 protease. Targeting the flavivirus NS2B/NS3 protease proved to be challenging because of the conformational dynamics, topology, and electrostatic properties of the active site. Here, we report the identification of quinoxaline-based allosteric inhibitors by fragment-based drug discovery approach as a promising new drug-like scaffold to target the NS2B/NS3 protease. Enzymatic assays and mutational analysis of the allosteric site in ZIKV NS2B/NS3 protease support noncompetitive inhibition mechanism as well as engineered DENV protease construct indicating the compounds likely compete with the NS2B cofactor for binding to the protease domain. Furthermore, antiviral activity confirmed the therapeutic potential of this new inhibitor scaffold.
科研通智能强力驱动
Strongly Powered by AbleSci AI